An update from Mineralys Therapeutics, Inc. ( (MLYS) ) is now available. Mineralys Therapeutics announced that the U.S. FDA ...
RADNOR, PA — Mineralys Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its ...
Mineralys Therapeutics, Inc. (MLYS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has announced the clearance of its investigational new drug (IND) application by ...
Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions ...
Two Philadelphia biotech companies scored approval in 2024 for first-of-their-kind gene therapy treatments for solid cancer tumors and melanoma. Those achievements by Iovance Biotherapeutics and ...
Bucking the trend, a number of Philadelphia-area life sciences companies raised more than $100 million in private equity ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) shot up 4% during trading on Friday .The stock traded as high as $13.43 and last traded at $13.39. 9,138 shares were traded ...